サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1426359

出生前および新生児遺伝子検査の世界市場レポート 2024

Prenatal And Newborn Genetic Testing Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
出生前および新生児遺伝子検査の世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

出生前および新生児遺伝子検査の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には12.5%の年間複合成長率（CAGR）で107億米ドルに成長すると予想されます。予測期間で予想される成長は、遺伝子検査パネルの拡大、母体の健康に対する意識の高まり、出生前および新生児スクリーニングガイドラインの順守、希少疾患への注目の高まり、および倫理と規制に関連する考慮事項に起因すると考えられます。予測期間中に予想される主な動向としては、非侵襲的出生前検査（NIPT）の普及、ゲノム配列決定（WGS）および全エクソーム配列決定の利用、遺伝子検査プロセスにおける人工知能（AI）の統合、遺伝子検査の実践、着床前遺伝子検査（PGT）、および消費者への直接の遺伝子検査の人気などが挙げられます。

出生前検査と新生児遺伝子スクリーニングに対する政府の取り組みと支援により、近い将来、出生前および新生児遺伝子検査市場の拡大が促進されると予想されます。このような取り組みには、特定の問題に対処したり、国民の福祉を促進したりするために、さまざまなレベルで政府機関によって導入された特定の行動、プログラム、政策が含まれます。 出生前および新生児遺伝子検査プログラムを提唱し、支援することで、政府は妊娠中または出生直後の胎児の遺伝子異常や状態の特定に貢献しています。この例は、2022年6月にオーストラリア政府がニューサウスウェールズ州（NSW州）の新生児スクリーニングプログラムに年間130万米ドルを割り当てたことに見られます。この資金により、重症複合型免疫不全症（SCID）と脊髄性筋萎縮症（SMA）の無料検査が促進されました。州内のすべての新生児に遺伝子スクリーニングを提供し、年間に生まれる10万人の乳児のうち、これらの遺伝性疾患を持つ13人の乳児の命を救う可能性があります。したがって、出生前および新生児の遺伝子スクリーニングを強化する政府の取り組みが、それぞれの検査市場の成長を推進しています。

遺伝性疾患の増加により、将来、出生前および新生児遺伝子検査市場の急増が促進されると予想されます。遺伝性疾患とは、個人のDNAまたは遺伝物質内の異常または突然変異によって生じる病状を指します。 出生前および新生児遺伝子検査は、これらの障害を初期段階（多くの場合、症状が明らかになる前）で特定する上で重要な役割を果たします。この早期発見により、ヘルスケア提供者はタイムリーな介入と治療戦略を開始できるようになり、そのような状態の影響を回避または軽減できる可能性があります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の出生前および新生児遺伝子検査市場、製品タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 消耗品
  • 機器
  • 世界の出生前および新生児遺伝子検査市場、スクリーニング別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 非侵襲的出生前検査
  • 慢性絨毛サンプリング
  • 羊水検査
  • 母体血清スクリーニング
  • その他のスクリーニング
  • 世界の出生前および新生児遺伝子検査市場、疾患別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ダウン症
  • フェニルケトン尿症
  • 嚢胞性線維症
  • 鎌状赤血球貧血
  • 世界の出生前および新生児遺伝子検査市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • 産科および専門クリニック
  • 診断センター

第7章 地域および国の分析

  • 世界の出生前および新生児遺伝子検査市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の出生前および新生児遺伝子検査市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 出生前および新生児遺伝子検査市場の競合情勢
  • 出生前および新生児遺伝子検査市場の企業プロファイル
    • F. Hoffmann-La Roche AG
    • Novartis AG
    • Sanofi SA
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories

第31章 その他の大手および革新的な企業

  • Danaher Corporation
  • Siemens Healthineers AG
  • Becton, Dickinson and Company
  • Quest Diagnostic Incorporated
  • Agilent Technologies Inc.
  • Grifols SA
  • Terumo Corporation
  • Illumina Inc.
  • PerkinElmer Genomics
  • Quidel Corporation
  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • Werfen SA
  • DiaSorin SpA
  • Nova Biomedical

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13371

Prenatal and newborn genetic testing encompasses medical procedures and screenings conducted during pregnancy and after birth to assess the genetic health and risk factors of both the developing fetus and the newborn baby. These tests are crucial for detecting and identifying genetic disorders, congenital conditions, or hereditary diseases that may impact the child's health or development.

The primary product types within the prenatal and newborn genetic testing domain include consumables and instruments. Instruments refer to specialized tools or devices designed for specific tasks or measurements, including various genetic analyzers used by healthcare professionals to conduct screenings and tests. Various screening methods include non-invasive prenatal testing, chronic villus sampling, amniocentesis, maternal serum screening, and others. The tests aim to identify diseases such as Down syndrome, phenylketonuria, cystic fibrosis, and sickle cell anemia. These genetic testing products find application across diverse end-users, including hospitals, maternity and specialty clinics, and diagnostic centers.

The prenatal and newborn genetic testing market research report is one of a series of new reports from The Business Research Company that provides prenatal and newborn genetic testing market statistics, including prenatal and newborn genetic testing industry global market size, regional shares, competitors with a prenatal and newborn genetic testing market share, detailed prenatal and newborn genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the prenatal and newborn genetic testing industry. This prenatal and newborn genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The prenatal and newborn genetic testing market size has grown rapidly in recent years. It will grow from $5.87 billion in 2023 to $6.68 billion in 2024 at a compound annual growth rate (CAGR) of 13.9%. The growth observed during the historic period can be attributed to several factors, including advancements in improved non-invasive prenatal testing methods, a rise in maternal age, support from governmental initiatives and healthcare policies, and increased patient demand for early detection of potential health issues during pregnancy.

The prenatal and newborn genetic testing market size is expected to see rapid growth in the next few years. It will grow to $10.7 billion in 2028 at a compound annual growth rate (CAGR) of 12.5%. The anticipated growth in the forecast period can be attributed to the expansion of genetic test panels, a growing awareness of maternal health, adherence to prenatal and newborn screening guidelines, an increased focus on rare diseases, and considerations related to ethics and regulations. Major trends expected during the forecast period include the widespread adoption of non-invasive prenatal testing (NIPT), the utilization of genome sequencing (WGS) and whole exome sequencing, the integration of artificial intelligence (AI) in genetic testing processes, the practice of preimplantation genetic testing (PGT), and the popularity of direct-to-consumer genetic testing.

Government initiatives and backing for prenatal testing and newborn genetic screening are anticipated to propel the expansion of the prenatal and newborn genetic testing markets in the foreseeable future. Such initiatives encompass specific actions, programs, or policies introduced by governmental bodies at various levels to address particular issues or promote the well-being of citizens. By advocating for and supporting prenatal and newborn genetic testing programs, governments contribute to the identification of genetic abnormalities or conditions in fetuses during pregnancy or shortly after birth. An illustration of this is seen in the Australian government's allocation of $1.3 million annually to the New South Wales (NSW) newborn screening program in June 2022. This funding facilitated free testing for severe combined immunodeficiency (SCID) and spinal muscular atrophy (SMA), providing genetic screening to all newborns in the state and potentially saving the lives of 13 infants with these genetic disorders among the 100,000 babies born yearly. Hence, government initiatives fortifying prenatal and newborn genetic screening drive the growth of the respective testing markets.

The mounting occurrence of genetic disorders is expected to drive the proliferation of the prenatal and newborn genetic testing market in the future. Genetic disorders denote medical conditions arising from abnormalities or mutations within an individual's DNA or genetic material. Prenatal and newborn genetic testing play a crucial role in identifying these disorders at an early stage, often before any symptoms become evident. This early identification enables healthcare providers to initiate timely interventions and treatment strategies, thus potentially averting or mitigating the impact of such conditions. For instance, statistics from 2021 from the Centers for Disease Control and Prevention (CDC) reveal that congenital disabilities affect approximately 3% of babies born in the United States annually, making them the leading cause of infant deaths, accounting for 20% of all infant mortalities. Hence, the rising incidence of genetic disorders propels the prenatal and newborn genetic testing market.

The ethical and legal ramifications present a potential impediment to the growth of the market in the forecast period. These implications refer to the consequences, considerations, and obligations linked to actions or decisions that encompass both ethical and legal facets. Within the prenatal and newborn genetic testing markets, ethical and legal concerns serve as constraints, impacting the accuracy and reliability of test outcomes while raising privacy and autonomy issues. For instance, as of July 2022, reports from the American Civil Liberties Union have highlighted authorities' attempts to access blood samples from newborns for criminal investigations. This exploitation of vast genetic data for law enforcement jeopardizes public trust in this vital health initiative and threatens genetic privacy rights by using this information to potentially link a child's relative to a crime. Consequently, ethical and legal implications related to genetic testing impede the prenatal and newborn genetic testing markets.

Leading companies in the prenatal and newborn genetic testing sectors are concentrating on developing innovative screening tests, particularly noninvasive prenatal screening tests, to enhance accessibility and affordability while ensuring dependable services for customers. Noninvasive prenatal screening (NIPS) or noninvasive prenatal testing (NIPT) represents an advanced and secure genetic screening method conducted during pregnancy to evaluate the risk of specific fetal chromosomal abnormalities. An instance of this advancement is Juno Diagnostics Inc.'s introduction of Juno Hazel in November 2022. This noninvasive prenatal screening test identifies chromosomal anomalies and offers clinical content using a sample collection kit, eliminating the necessity for phlebotomy and enhancing accessibility. Additionally, the company intends to provide educational resources and personalized genetic counseling support by partnering with healthcare professionals and genetic counselors.

In July 2021, Genetic Technologies Limited, an Australia-based biotechnology research firm, completed the acquisition of EasyDNA for $4 million. This strategic move by Genetic Technologies Limited is designed to broaden its geographic presence and harness the specialized skills and capabilities of EasyDNA. The objective behind this acquisition is to facilitate the development, production, and increased accessibility of carrier testing and non-invasive prenatal tests (NIPT), thereby catering to previously unaddressed market requirements. EasyDNA, a Malta-based company, specializes in DNA testing services, particularly in pre-conception and prenatal testing.

Major companies operating in the prenatal and newborn genetic testing market report are F. Hoffmann-La Roche AG, Novartis AG, Sanofi S.A., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson and Company, Quest Diagnostic Incorporated, Agilent Technologies Inc., Grifols S.A., Terumo Corporation, Illumina Inc., PerkinElmer Genomics, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen NV, Werfen S.A., DiaSorin S.p.A, Nova Biomedical, BGI Group, Natera Inc., Trinity Biotech plc, Meridian Bioscience Inc., Sekisui Diagnostics, Chembio Diagnostics, PTS Diagnostics, Ariosa Diagnostics Inc., AccuBioTech Co. Ltd., Sequenom Inc.

North America was the largest region in the prenatal and newborn genetic testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the prenatal and newborn genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The prenatal and newborn genetic testing market consists of revenues earned by entities by providing services such as prenatal screening tests, prenatal diagnostic tests, carrier screening for genetic conditions, and newborn screening tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The prenatal and newborn genetic testing market also includes sales of electrophoresis equipment, genetic sequencing machines, and microarray analysis instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Prenatal And Newborn Genetic Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prenatal and newborn genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prenatal and newborn genetic testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The prenatal and newborn genetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Product Type: Consumables; Instruments
  • 2) By Screening: Non-Invasive Prenatal Testing; Chronic Villus Sampling; Amniocentesis; Maternal Serum Screening; Other Screenings
  • 3) By Disease: Down Syndrome; Phenylketonuria; Cystic Fibrosis; Sickle Cell Anemia
  • 4) By End User: Hospital; Maternity And Specialty Clinics; Diagnostic Centers
  • Companies Mentioned: F. Hoffmann-La Roche AG; Novartis AG; Sanofi S.A.; Thermo Fisher Scientific Inc.; Abbott Laboratories
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Prenatal And Newborn Genetic Testing Market Characteristics

3. Prenatal And Newborn Genetic Testing Market Trends And Strategies

4. Prenatal And Newborn Genetic Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Prenatal And Newborn Genetic Testing Market Size and Growth

  • 5.1. Global Prenatal And Newborn Genetic Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Prenatal And Newborn Genetic Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Prenatal And Newborn Genetic Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Prenatal And Newborn Genetic Testing Market Segmentation

  • 6.1. Global Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Consumables
  • Instruments
  • 6.2. Global Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Non-Invasive Prenatal Testing
  • Chronic Villus Sampling
  • Amniocentesis
  • Maternal Serum Screening
  • Other Screenings
  • 6.3. Global Prenatal And Newborn Genetic Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Down Syndrome
  • Phenylketonuria
  • Cystic Fibrosis
  • Sickle Cell Anemia
  • 6.4. Global Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital
  • Maternity And Specialty Clinics
  • Diagnostic Centers

7. Prenatal And Newborn Genetic Testing Market Regional And Country Analysis

  • 7.1. Global Prenatal And Newborn Genetic Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Prenatal And Newborn Genetic Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Prenatal And Newborn Genetic Testing Market

  • 8.1. Asia-Pacific Prenatal And Newborn Genetic Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Prenatal And Newborn Genetic Testing Market

  • 9.1. China Prenatal And Newborn Genetic Testing Market Overview
  • 9.2. China Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Prenatal And Newborn Genetic Testing Market

  • 10.1. India Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Prenatal And Newborn Genetic Testing Market

  • 11.1. Japan Prenatal And Newborn Genetic Testing Market Overview
  • 11.2. Japan Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Prenatal And Newborn Genetic Testing Market

  • 12.1. Australia Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Prenatal And Newborn Genetic Testing Market

  • 13.1. Indonesia Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Prenatal And Newborn Genetic Testing Market

  • 14.1. South Korea Prenatal And Newborn Genetic Testing Market Overview
  • 14.2. South Korea Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Prenatal And Newborn Genetic Testing Market

  • 15.1. Western Europe Prenatal And Newborn Genetic Testing Market Overview
  • 15.2. Western Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Prenatal And Newborn Genetic Testing Market

  • 16.1. UK Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Prenatal And Newborn Genetic Testing Market

  • 17.1. Germany Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Prenatal And Newborn Genetic Testing Market

  • 18.5. France Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Prenatal And Newborn Genetic Testing Market

  • 19.9. Italy Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Prenatal And Newborn Genetic Testing Market

  • 20.13. Spain Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Prenatal And Newborn Genetic Testing Market

  • 21.1. Eastern Europe Prenatal And Newborn Genetic Testing Market Overview
  • 21.2. Eastern Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Prenatal And Newborn Genetic Testing Market

  • 22.1. Russia Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Prenatal And Newborn Genetic Testing Market

  • 23.1. North America Prenatal And Newborn Genetic Testing Market Overview
  • 23.2. North America Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Prenatal And Newborn Genetic Testing Market

  • 24.1. USA Prenatal And Newborn Genetic Testing Market Overview
  • 24.2. USA Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Prenatal And Newborn Genetic Testing Market

  • 25.1. Canada Prenatal And Newborn Genetic Testing Market Overview
  • 25.2. Canada Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Prenatal And Newborn Genetic Testing Market

  • 26.1. South America Prenatal And Newborn Genetic Testing Market Overview
  • 26.2. South America Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Prenatal And Newborn Genetic Testing Market

  • 27.1. Brazil Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Prenatal And Newborn Genetic Testing Market

  • 28.1. Middle East Prenatal And Newborn Genetic Testing Market Overview
  • 28.2. Middle East Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Prenatal And Newborn Genetic Testing Market

  • 29.1. Africa Prenatal And Newborn Genetic Testing Market Overview
  • 29.2. Africa Prenatal And Newborn Genetic Testing Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Prenatal And Newborn Genetic Testing Market, Segmentation By Screening, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Prenatal And Newborn Genetic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Prenatal And Newborn Genetic Testing Market Competitive Landscape And Company Profiles

  • 30.1. Prenatal And Newborn Genetic Testing Market Competitive Landscape
  • 30.2. Prenatal And Newborn Genetic Testing Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Novartis AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Sanofi S.A.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Thermo Fisher Scientific Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Abbott Laboratories
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Prenatal And Newborn Genetic Testing Market Other Major And Innovative Companies

  • 31.1. Danaher Corporation
  • 31.2. Siemens Healthineers AG
  • 31.3. Becton, Dickinson and Company
  • 31.4. Quest Diagnostic Incorporated
  • 31.5. Agilent Technologies Inc.
  • 31.6. Grifols S.A.
  • 31.7. Terumo Corporation
  • 31.8. Illumina Inc.
  • 31.9. PerkinElmer Genomics
  • 31.10. Quidel Corporation
  • 31.11. Bio-Rad Laboratories Inc.
  • 31.12. Qiagen NV
  • 31.13. Werfen S.A.
  • 31.14. DiaSorin S.p.A
  • 31.15. Nova Biomedical

32. Global Prenatal And Newborn Genetic Testing Market Competitive Benchmarking

33. Global Prenatal And Newborn Genetic Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Prenatal And Newborn Genetic Testing Market

35. Prenatal And Newborn Genetic Testing Market Future Outlook and Potential Analysis

  • 35.1 Prenatal And Newborn Genetic Testing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Prenatal And Newborn Genetic Testing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Prenatal And Newborn Genetic Testing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer